葵花药业：夫西地酸乳膏申请注册上市许可获受理

Core Viewpoint - The announcement from Kew Flower Pharmaceutical indicates the acceptance of the registration application for Fusidic Acid Cream by the National Medical Products Administration, which is a significant step towards market entry for this product [1] Group 1: Company Information - Kew Flower Pharmaceutical's wholly-owned subsidiary, Harbin Kew Flower Pharmaceutical Co., Ltd., has received the acceptance notice for the registration of Fusidic Acid Cream [1] - The primary indications for this medication include various skin infections such as pustules, boils, carbuncles, paronychia, wound infections, furuncles, sweat gland inflammation, erythema, folliculitis, and common acne [1] - The cream is suitable for use on facial and scalp infections without affecting appearance [1]